APO Research
Talk to an analyst

APO RESEARCH · REPORT

API Drug Development Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global API Drug Development Service Industry Growth and Trends Forecast to 2032

2 May 2026113 pages

Choose your research edition.

Industry ResearchAPI Drug Development Service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal API Drug Development Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal API Drug Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal API Drug Development Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal API Drug Development Service Market Analysis and Forecast 2026-2032244 pages · $4,950 USD

Market perspective

According to APO Research, the global API Drug Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for API Drug Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for API Drug Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for API Drug Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the API Drug Development Service market include Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific and Malvern Panalytical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global API Drug Development Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The API Drug Development Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global API Drug Development Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to API Drug Development Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global API Drug Development Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

API Drug Development Service Market by Company

Lonza

Patheon

Catalent

Carbogen Amcis

Sterling Pharma Solutions

Cambrex

CordenPharma

Eurofins Scientific

Malvern Panalytical

Almac

Pfizer

Axplora

Aptuit

Porton

Pharmaron Beijing

Shanghai Haoyuan Chemexpress

Stapharma

API Drug Development Service Segment by Type

Captive Product Development Service

Commercial Product Development Service

API Drug Development Service Segment by Application

Small Biotechs Companies

Large Pharmaceutical Organizations

API Drug Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global API Drug Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of API Drug Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of API Drug Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of API Drug Development Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global API Drug Development Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global API Drug Development Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global API Drug Development Service Market Share by Region (2021-2026) Table 4. Global API Drug Development Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global API Drug Development Service Market Share by Region (2027-2032) Table 6. Global API Drug Development Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global API Drug Development Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global API Drug Development Service Market Size Share by Type (2021-2026) Table 9. Global API Drug Development Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global API Drug Development Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America API Drug Development Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America API Drug Development Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe API Drug Development Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe API Drug Development Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific API Drug Development Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific API Drug Development Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America API Drug Development Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America API Drug Development Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa API Drug Development Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa API Drug Development Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global API Drug Development Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global API Drug Development Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global API Drug Development Service Market Size Share by Application (2021-2026) Table 24. Global API Drug Development Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global API Drug Development Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America API Drug Development Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America API Drug Development Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe API Drug Development Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe API Drug Development Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific API Drug Development Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific API Drug Development Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America API Drug Development Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America API Drug Development Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa API Drug Development Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa API Drug Development Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. API Drug Development Service Industry Trends Table 37. API Drug Development Service Industry Drivers Table 38. API Drug Development Service Industry Opportunities and Challenges Table 39. API Drug Development Service Industry Restraints Table 40. Global API Drug Development Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global API Drug Development Service Revenue Market Share by Company (2021-2026) Table 42. Global API Drug Development Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global API Drug Development Service Key Company Headquarters & Area Served Table 44. Global API Drug Development Service Company, Product Type & Application Table 45. Global API Drug Development Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global API Drug Development Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Company Information Table 49. Lonza Business Overview Table 50. Lonza API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza API Drug Development Service Product Portfolio Table 52. Lonza Recent Development Table 53. Patheon Company Information Table 54. Patheon Business Overview Table 55. Patheon API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Patheon API Drug Development Service Product Portfolio Table 57. Patheon Recent Development Table 58. Catalent Company Information Table 59. Catalent Business Overview Table 60. Catalent API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Catalent API Drug Development Service Product Portfolio Table 62. Catalent Recent Development Table 63. Carbogen Amcis Company Information Table 64. Carbogen Amcis Business Overview Table 65. Carbogen Amcis API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Carbogen Amcis API Drug Development Service Product Portfolio Table 67. Carbogen Amcis Recent Development Table 68. Sterling Pharma Solutions Company Information Table 69. Sterling Pharma Solutions Business Overview Table 70. Sterling Pharma Solutions API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sterling Pharma Solutions API Drug Development Service Product Portfolio Table 72. Sterling Pharma Solutions Recent Development Table 73. Cambrex Company Information Table 74. Cambrex Business Overview Table 75. Cambrex API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cambrex API Drug Development Service Product Portfolio Table 77. Cambrex Recent Development Table 78. CordenPharma Company Information Table 79. CordenPharma Business Overview Table 80. CordenPharma API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. CordenPharma API Drug Development Service Product Portfolio Table 82. CordenPharma Recent Development Table 83. Eurofins Scientific Company Information Table 84. Eurofins Scientific Business Overview Table 85. Eurofins Scientific API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eurofins Scientific API Drug Development Service Product Portfolio Table 87. Eurofins Scientific Recent Development Table 88. Malvern Panalytical Company Information Table 89. Malvern Panalytical Business Overview Table 90. Malvern Panalytical API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Malvern Panalytical API Drug Development Service Product Portfolio Table 92. Malvern Panalytical Recent Development Table 93. Almac Company Information Table 94. Almac Business Overview Table 95. Almac API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Almac API Drug Development Service Product Portfolio Table 97. Almac Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pfizer API Drug Development Service Product Portfolio Table 102. Pfizer Recent Development Table 103. Axplora Company Information Table 104. Axplora Business Overview Table 105. Axplora API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Axplora API Drug Development Service Product Portfolio Table 107. Axplora Recent Development Table 108. Aptuit Company Information Table 109. Aptuit Business Overview Table 110. Aptuit API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Aptuit API Drug Development Service Product Portfolio Table 112. Aptuit Recent Development Table 113. Porton Company Information Table 114. Porton Business Overview Table 115. Porton API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Porton API Drug Development Service Product Portfolio Table 117. Porton Recent Development Table 118. Pharmaron Beijing Company Information Table 119. Pharmaron Beijing Business Overview Table 120. Pharmaron Beijing API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Pharmaron Beijing API Drug Development Service Product Portfolio Table 122. Pharmaron Beijing Recent Development Table 123. Shanghai Haoyuan Chemexpress Company Information Table 124. Shanghai Haoyuan Chemexpress Business Overview Table 125. Shanghai Haoyuan Chemexpress API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Shanghai Haoyuan Chemexpress API Drug Development Service Product Portfolio Table 127. Shanghai Haoyuan Chemexpress Recent Development Table 128. Stapharma Company Information Table 129. Stapharma Business Overview Table 130. Stapharma API Drug Development Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Stapharma API Drug Development Service Product Portfolio Table 132. Stapharma Recent Development Table 133. North America API Drug Development Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America API Drug Development Service Market Size by Country (2021-2026) & (US$ Million) Table 135. North America API Drug Development Service Market Share by Country (2021-2026) Table 136. North America API Drug Development Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America API Drug Development Service Market Share Forecast by Country (2027-2032) Table 138. Europe API Drug Development Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe API Drug Development Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe API Drug Development Service Market Share by Country (2021-2026) Table 141. Europe API Drug Development Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe API Drug Development Service Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific API Drug Development Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific API Drug Development Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific API Drug Development Service Market Share by Country (2021-2026) Table 146. Asia-Pacific API Drug Development Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific API Drug Development Service Market Share Forecast by Country (2027-2032) Table 148. Latin America API Drug Development Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America API Drug Development Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America API Drug Development Service Market Share by Country (2021-2026) Table 151. Latin America API Drug Development Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America API Drug Development Service Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa API Drug Development Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa API Drug Development Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa API Drug Development Service Market Share by Country (2021-2026) Table 156. Middle East & Africa API Drug Development Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa API Drug Development Service Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. API Drug Development Service Product Image Figure 3. Global API Drug Development Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global API Drug Development Service Market Size (2021-2032) & (US$ Million) Figure 5. Global API Drug Development Service Market Share by Region: 2025 VS 2032 Figure 6. Global API Drug Development Service Market Share by Region (2021-2032) Figure 7. North America API Drug Development Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe API Drug Development Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific API Drug Development Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America API Drug Development Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa API Drug Development Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Captive Product Development Service Image Figure 13. Global Captive Product Development Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Commercial Product Development Service Image Figure 15. Global Commercial Product Development Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global API Drug Development Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global API Drug Development Service Market Share by Type 2025 VS 2032 Figure 18. North America API Drug Development Service Market Size Share by Type (2021-2032) Figure 19. Europe API Drug Development Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific API Drug Development Service Market Size Share by Type (2021-2032) Figure 21. Latin America API Drug Development Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa API Drug Development Service Market Size Share by Type (2021-2032) Figure 23. Small Biotechs Companies Image Figure 24. Global Small Biotechs Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Large Pharmaceutical Organizations Image Figure 26. Global Large Pharmaceutical Organizations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global API Drug Development Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global API Drug Development Service Market Share by Application 2025 VS 2032 Figure 29. North America API Drug Development Service Market Size Share by Application (2021-2032) Figure 30. Europe API Drug Development Service Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific API Drug Development Service Market Size Share by Application (2021-2032) Figure 32. Latin America API Drug Development Service Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa API Drug Development Service Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 API Drug Development Service Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America API Drug Development Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America API Drug Development Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America API Drug Development Service Market Share by Country (2021-2032) Figure 39. Europe API Drug Development Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe API Drug Development Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe API Drug Development Service Market Share by Country (2021-2032) Figure 42. Asia-Pacific API Drug Development Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific API Drug Development Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific API Drug Development Service Market Share by Country (2021-2032) Figure 45. Latin America API Drug Development Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America API Drug Development Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America API Drug Development Service Market Share by Country (2021-2032) Figure 48. Middle East & Africa API Drug Development Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa API Drug Development Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa API Drug Development Service Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Captive Product Development Service
  • Commercial Product Development Service
Applications
  • Small Biotechs Companies
  • Large Pharmaceutical Organizations
Companies covered
  • Lonza
  • Patheon
  • Catalent
  • Carbogen Amcis
  • Sterling Pharma Solutions
  • Cambrex
  • CordenPharma
  • Eurofins Scientific
  • Malvern Panalytical
  • Almac
  • Pfizer
  • Axplora
  • Aptuit
  • Porton
  • Pharmaron Beijing
  • Shanghai Haoyuan Chemexpress
  • Stapharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global API Drug Development Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global API Drug Development Service Market Size by Region (2021-2032)
  5. 1.4.1 Global API Drug Development Service Market Size by Region (2021-2026)
  6. 1.4.2 Global API Drug Development Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions API Drug Development Service Market Size (2021-2032)
  8. 1.5.1 North America API Drug Development Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe API Drug Development Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific API Drug Development Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America API Drug Development Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa API Drug Development Service Market Size Growth Rate (2021-2032)
2 API Drug Development Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Captive Product Development Service
  3. 2.1.2 Commercial Product Development Service
  4. 2.2 Global API Drug Development Service Market Size by Type
  5. 2.2.1 Global API Drug Development Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global API Drug Development Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global API Drug Development Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global API Drug Development Service Market Size by Regions
  9. 2.3.1 North America API Drug Development Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe API Drug Development Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific API Drug Development Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America API Drug Development Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa API Drug Development Service Market Size Breakdown by Type (2021-2026)
3 API Drug Development Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Small Biotechs Companies
  3. 3.1.2 Large Pharmaceutical Organizations
  4. 3.2 Global API Drug Development Service Market Size by Application
  5. 3.2.1 Global API Drug Development Service Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global API Drug Development Service Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global API Drug Development Service Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global API Drug Development Service Market Size by Regions
  9. 3.3.1 North America API Drug Development Service Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe API Drug Development Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific API Drug Development Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America API Drug Development Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa API Drug Development Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 API Drug Development Service Industry Trends
  2. 4.2 API Drug Development Service Industry Drivers
  3. 4.3 API Drug Development Service Industry Opportunities and Challenges
  4. 4.4 API Drug Development Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by API Drug Development Service Revenue (2021-2026)
  2. 5.2 Global API Drug Development Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global API Drug Development Service Key Company Headquarters & Area Served
  4. 5.4 Global API Drug Development Service Company, Product Type & Application
  5. 5.5 Global API Drug Development Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global API Drug Development Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 API Drug Development Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 API Drug Development Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza API Drug Development Service Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Patheon
  8. 6.2.1 Patheon Company Information
  9. 6.2.2 Patheon Business Overview
  10. 6.2.3 Patheon API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Patheon API Drug Development Service Product Portfolio
  12. 6.2.5 Patheon Recent Developments
  13. 6.3 Catalent
  14. 6.3.1 Catalent Company Information
  15. 6.3.2 Catalent Business Overview
  16. 6.3.3 Catalent API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Catalent API Drug Development Service Product Portfolio
  18. 6.3.5 Catalent Recent Developments
  19. 6.4 Carbogen Amcis
  20. 6.4.1 Carbogen Amcis Company Information
  21. 6.4.2 Carbogen Amcis Business Overview
  22. 6.4.3 Carbogen Amcis API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Carbogen Amcis API Drug Development Service Product Portfolio
  24. 6.4.5 Carbogen Amcis Recent Developments
  25. 6.5 Sterling Pharma Solutions
  26. 6.5.1 Sterling Pharma Solutions Company Information
  27. 6.5.2 Sterling Pharma Solutions Business Overview
  28. 6.5.3 Sterling Pharma Solutions API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sterling Pharma Solutions API Drug Development Service Product Portfolio
  30. 6.5.5 Sterling Pharma Solutions Recent Developments
  31. 6.6 Cambrex
  32. 6.6.1 Cambrex Company Information
  33. 6.6.2 Cambrex Business Overview
  34. 6.6.3 Cambrex API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cambrex API Drug Development Service Product Portfolio
  36. 6.6.5 Cambrex Recent Developments
  37. 6.7 CordenPharma
  38. 6.7.1 CordenPharma Company Information
  39. 6.7.2 CordenPharma Business Overview
  40. 6.7.3 CordenPharma API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 CordenPharma API Drug Development Service Product Portfolio
  42. 6.7.5 CordenPharma Recent Developments
  43. 6.8 Eurofins Scientific
  44. 6.8.1 Eurofins Scientific Company Information
  45. 6.8.2 Eurofins Scientific Business Overview
  46. 6.8.3 Eurofins Scientific API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eurofins Scientific API Drug Development Service Product Portfolio
  48. 6.8.5 Eurofins Scientific Recent Developments
  49. 6.9 Malvern Panalytical
  50. 6.9.1 Malvern Panalytical Company Information
  51. 6.9.2 Malvern Panalytical Business Overview
  52. 6.9.3 Malvern Panalytical API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Malvern Panalytical API Drug Development Service Product Portfolio
  54. 6.9.5 Malvern Panalytical Recent Developments
  55. 6.10 Almac
  56. 6.10.1 Almac Company Information
  57. 6.10.2 Almac Business Overview
  58. 6.10.3 Almac API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Almac API Drug Development Service Product Portfolio
  60. 6.10.5 Almac Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer API Drug Development Service Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Axplora
  68. 6.12.1 Axplora Company Information
  69. 6.12.2 Axplora Business Overview
  70. 6.12.3 Axplora API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Axplora API Drug Development Service Product Portfolio
  72. 6.12.5 Axplora Recent Developments
  73. 6.13 Aptuit
  74. 6.13.1 Aptuit Company Information
  75. 6.13.2 Aptuit Business Overview
  76. 6.13.3 Aptuit API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Aptuit API Drug Development Service Product Portfolio
  78. 6.13.5 Aptuit Recent Developments
  79. 6.14 Porton
  80. 6.14.1 Porton Company Information
  81. 6.14.2 Porton Business Overview
  82. 6.14.3 Porton API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Porton API Drug Development Service Product Portfolio
  84. 6.14.5 Porton Recent Developments
  85. 6.15 Pharmaron Beijing
  86. 6.15.1 Pharmaron Beijing Company Information
  87. 6.15.2 Pharmaron Beijing Business Overview
  88. 6.15.3 Pharmaron Beijing API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Pharmaron Beijing API Drug Development Service Product Portfolio
  90. 6.15.5 Pharmaron Beijing Recent Developments
  91. 6.16 Shanghai Haoyuan Chemexpress
  92. 6.16.1 Shanghai Haoyuan Chemexpress Company Information
  93. 6.16.2 Shanghai Haoyuan Chemexpress Business Overview
  94. 6.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Shanghai Haoyuan Chemexpress API Drug Development Service Product Portfolio
  96. 6.16.5 Shanghai Haoyuan Chemexpress Recent Developments
  97. 6.17 Stapharma
  98. 6.17.1 Stapharma Company Information
  99. 6.17.2 Stapharma Business Overview
  100. 6.17.3 Stapharma API Drug Development Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Stapharma API Drug Development Service Product Portfolio
  102. 6.17.5 Stapharma Recent Developments
7 North America
  1. 7.1 North America API Drug Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America API Drug Development Service Market Size by Country (2021-2026)
  3. 7.3 North America API Drug Development Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe API Drug Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe API Drug Development Service Market Size by Country (2021-2026)
  3. 8.3 Europe API Drug Development Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific API Drug Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific API Drug Development Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific API Drug Development Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America API Drug Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America API Drug Development Service Market Size by Country (2021-2026)
  3. 10.3 South America API Drug Development Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa API Drug Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa API Drug Development Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa API Drug Development Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst